1,450 results on '"Becker, Jürgen C."'
Search Results
202. Chemoimmunotherapy for melanoma with dacarbazine and 2,4-dinitrochlorobenzene elicits a specific T cell-dependent immune response
203. Merkel Cell Polyomavirus
204. Diagnostic and Prognostic Biomarkers in Melanoma: Current State of Play
205. Basic Pathobiology of Merkel Cell Carcinoma
206. Association Between Merkel Cell Polyomavirus and Merkel Cell Carcinoma
207. The Potential for Targeted Therapy of Merkel Cell Carcinoma
208. Other Therapies
209. Pathogenesis of Merkel Cell Carcinoma
210. Neural Tumors
211. Comparative delineation of T cell clonotypes in coexisting syngeneic B16 melanoma
212. Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cells
213. Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
214. An intact retinoblastoma protein-binding site in Merkel cell polyomavirus large T antigen is required for promoting growth of Merkel cell carcinoma cells
215. Function and dysfunction of CD4+ T cells in the immune response to melanoma
216. In situ T cells in melanoma
217. Management of cutaneous side effects of EGFR inhibitors: recommendations from a German expert panel for the primary treating physician
218. Management kutaner Nebenwirkungen von EGFR-Inhibitoren: Empfehlungen eines deutschen Expertengremiums für den primär behandelnden Arzt
219. Homo- and heterotypic cell-cell contacts in Merkel cells and Merkel cell carcinomas: heterogeneity and indications for cadherin switching
220. High-resolution analysis of Merkel Cell Polyomavirus in Merkel Cell Carcinoma reveals distinct integration patterns and suggests NHEJ and MMBIR as underlying mechanisms
221. Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy
222. Differences in site‐specific incidence and relative survival of cutaneous and mucocutaneous genital squamous cell carcinoma in Germany, 2007‐2015
223. A digital mRNA expression signature to classify challenging Spitzoid melanocytic neoplasms
224. A phase I dose-escalation and expansion study of intratumoral CV8102 as single-agent or in combination with anti-PD-1 antibodies in patients with advanced solid tumors.
225. MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas
226. Impact of a preceding radiotherapy on the outcome of immune checkpoint inhibition in metastatic melanoma: a multicenter retrospective cohort study of the DeCOG
227. Adjuvant nivolumab plus ipilimumab or nivolumab monotherapy versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): a randomised, double-blind, placebo-controlled, phase 2 trial
228. Predominance of Central Memory T Cells with High T-Cell Receptor Repertoire Diversity is Associated with Response to PD-1/PD-L1 Inhibition in Merkel Cell Carcinoma
229. Survival of patients with advanced metastatic melanoma: The impact of MAP kinase pathway inhibition and immune checkpoint inhibition - Update 2019
230. Artesunate Affects T Antigen Expression and Survival of Virus-Positive Merkel Cell Carcinoma
231. S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma (cSCC) – short version, part 2: epidemiology, surgical and systemic treatment of cSCC, follow‐up, prevention and occupational disease
232. S3‐Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Kurzfassung, Teil 2: Epidemiologie, chirurgische und systemische Therapie des Plattenepithelkarzinoms, Nachsorge, Prävention und Berufskrankheit
233. Persister state-directed transitioning and vulnerability in melanoma
234. Expression of Programmed Cell Death Proteins in Kaposi Sarcoma and Cutaneous Angiosarcoma
235. S3 guideline for actinic keratosis and cutaneous squamous cell carcinoma – short version, part 1: diagnosis, interventions for actinic keratoses, care structures and quality‐of‐care indicators
236. S3‐Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ – Kurzfassung, Teil 1: Diagnostik, Interventionen bei aktinischen Keratosen, Versorgungsstrukturen und Qualitätsindikatoren
237. Molecular Profiling of Keratinocyte Skin Tumors Links Staphylococcus aureus Overabundance and Increased Human β-Defensin-2 Expression to Growth Promotion of Squamous Cell Carcinoma
238. Highly Expressed miR-375 is not an Intracellular Oncogene in Merkel Cell Polyomavirus-Associated Merkel Cell Carcinoma
239. MCPyV Large T Antigen-Induced Atonal Homolog 1 Is a Lineage-Dependency Oncogene in Merkel Cell Carcinoma
240. Staphylococcus aureus alpha-toxin inhibits CD8+ T cell-mediated killing of cancer cells in cutaneous T-cell lymphoma
241. Immunochemotherapie des metastasierenden Uveamelanoms mit Interferon-α2b, Interleukin-2 und Fotemustin Kasuistiken und Literaturübersicht: Kasuistiken und Literaturübersicht
242. Phototherapie und photodynamische Therapie: Theorie und praktische Anwendungen
243. Hautkrebsrisiko durch topische Immunmodulatoren: Ende der Debatte?
244. Serum neuron‐specific enolase independently predicts outcomes of patients with Merkel cell carcinoma.
245. A novel xenograft model of cutaneous T-cell lymphoma
246. Application of Circulating Cell-Free Tumor DNA Profiles for Therapeutic Monitoring and Outcome Prediction in Genetically Heterogeneous Metastatic Melanoma
247. Durable Complete Remission of Therapy-Refractory, Tumor-Stage Cutaneous T-Cell Lymphoma Under Radioimmunotherapy With Electron Beam Irradiation and Denileukin Diftitox
248. COX-2-Dependent PGE2 Acts as Growth Factor in Mycosis Fungoides (MF): PS-045
249. Distinction of 2 Different Primary Merkel Cell Carcinomas in 1 Patient by Merkel Cell Polyomavirus Genome Analysis
250. Highly expressed miR-375 is not an intracellular oncogene in Merkel cell polyomavirus-associated Merkel cell carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.